Markets Gone Wild

RLF-TD011 Investigator-Initiated Trial Results and RLF-OD032 Progress Update Geneva, Switzerland / August 30, 2024 / Relief Therapeutics Holding SA (SIX:RLF) (OTCQB:RLFTF) (OTCQB:RLFTY) Financial Update and Corporate Outlook RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company dedicated to advancing treatment options for select specialty, unmet, and rare diseases, recently disclosed its financial results for the half-year ended…

Exciting News in the Biopharmaceutical Industry ABVC BioPharma Receives Cash Payment from OncoX BioPharma FREMONT, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) — ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic solutions in ophthalmology, CNS (central nervous system), and oncology/hematology, announced the receipt of a $200,000 cash payment from OncoX BioPharma Inc. (“OncoX”)…

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Integral Ad Science Holding Corp. LOS ANGELES, CA / ACCESS Newswire / February 7, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, is reminding investors of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or “the Company”)…

Welcome to the Wacky World of Energy Transfers The Drama Unfolds: Energy Transfer’s Rollercoaster Ride So, here we are, witnessing the wild ride that is Energy Transfer. Despite putting on a spectacular show in FY24, its units are down 3%. Why, you ask? Well, it seems that investors are a tad bit jittery about the…

Investors Encouraged to Lead Securities Fraud Lawsuit Against Symbotic Inc. LOS ANGELES, Jan. 30, 2025 Overview Glancy Prongay & Murray LLP has announced that investors who have suffered losses have the opportunity to lead a securities fraud class action lawsuit against Symbotic Inc. If you have experienced a loss on your Symbotic investments, it is…